Integra LifeSciences/IART

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Integra LifeSciences

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Ticker

IART

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Stuart Essig

Employees

3,946

Headquarters

Princeton, United States

IART Metrics

BasicAdvanced
$2.4B
Market cap
60.84
P/E ratio
$0.51
EPS
1.17
Beta
-
Dividend rate
$2.4B
1.17114
$46.75
$22.36
1.1M
4.681
3.347
114.936
116.148
38.372
6.66%
1.03%
2.46%
1.11%
60.841
1.592
1.523
39.963
-2.07%
-75.41%
3.96%
-18.73%

What the Analysts think about IART

Analyst Ratings

Majority rating from 14 analysts.
Hold

IART Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-0.86% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$369M
-7.10%
Net income
-$3.2M
-116.16%
Profit margin
-0.86%
-117.27%

IART Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.30%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.71
$0.76
$0.89
$0.55
-
Expected
$0.57
$0.78
$0.90
$0.55
$0.62
Surprise
24.76%
-2.30%
-1.46%
-0.30%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Integra LifeSciences stock?

Integra LifeSciences (IART) has a market cap of $2.4B as of June 17, 2024.

What is the P/E ratio for Integra LifeSciences stock?

The price to earnings (P/E) ratio for Integra LifeSciences (IART) stock is 60.84 as of June 17, 2024.

Does Integra LifeSciences stock pay dividends?

No, Integra LifeSciences (IART) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next Integra LifeSciences dividend payment date?

Integra LifeSciences (IART) stock does not pay dividends to its shareholders.

What is the beta indicator for Integra LifeSciences?

Integra LifeSciences (IART) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Integra LifeSciences stock price target?

The target price for Integra LifeSciences (IART) stock is $33.25, which is NaN% below the current price of $. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Integra LifeSciences stock

Buy or sell Integra LifeSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing